Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA

Journal of Immunology

Volumn 166, Issue 5, 2001, Pages 2953-2960

  Heiser, A ^a   Maurice, M A ^a   Yancey, D R ^a   Wu, N Z ^a   Dahm, P ^a   Pruitt, S K ^a   Boczkowski, D ^a   Nair, S K ^a   Ballo, M S ^a   Gilboa, E ^a   Vieweg, J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; PROSTATE SPECIFIC ANTIGEN; RNA; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ANTIGEN EXPRESSION; ARTICLE; CHROMOSOME MICRODISSECTION; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENE AMPLIFICATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR CELL; TUMOR ESCAPE;

EID: 0035284901     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.5.2953     Document Type: Article

References (27)

1. Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro
2. Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity
3. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
4. How much longer will tumour cells fool the immune system?
5. The makings of a tumor rejection antigen
6. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
7. Melanomas with concordant loss of multiple melanocytic differentiation proteins: Immune escape that may be overcome by targeting unique or undefined antigens
8. Antigen loss variants of a murine renal cell carcinoma: Implications for tumor vaccination
9. Unique tumor antigens redefined as mutant tumor-specific antigens
10. On the role of antigen in maintaining cytotoxic T-cell memory
11. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells
12. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: Implications for live kidney cancer vaccines
13. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
14. Immunotherapy of cancer with dendritic-cell-based vaccines
15. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells
16. Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability
17. Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-α for use in cancer immunotherapy
18. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
19. Use of single stranded conformational polymorphism (SSCP) for analysis of the T cell receptor
20. Generation of TCR spectratypes by multiplex PCR for T cell repertoire analysis
21. Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells
22. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells
23. Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA
24. Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
25. Laser capture microdissection
26. Simple, reliable detection of T cell clones by PCR-LIS-SSCP analysis of TCRγ rearrangement
27. Transfected human dendritic cells as cancer vaccines